FDA warns on abortion pill infection risk

Share this article:
The FDA warned doctors yesterday to be on the lookout for rare but deadly bacterial infections in women using Danco Laboratories' abortion pill RU-486.
The warning stated that four women have died from sepsis, an infection of the bloodstream, following use of the drug, also known as Mifeprex.
Although all of the cases were reported in California and involve the off-label use of the drug, the FDA is asking all doctors to look for the symptoms of the infection while the agency reviews the cases.
 
Share this article:

Email Newsletters

More in Business Briefs

Imbruvica lassoes CLL indication

The FDA slapped a Breakthrough Therapy label on the CLL indication pursuit in February.

FDA asks social media "how'm I doin?"

The FDA's Center for Drug Evaluation and Research's Office of Communications wants a system that will help assess its messaging reach across the interwebs and its many forums.

Reckitt Benckiser wants out of pharma

The company plans to spin off its pharmaceutical unit.